The biopharma world's manufacturing weekly

Endpoints Manufacturing

Manufacturing channel feed

Covid vac­cine roundup: US vac­cine sup­plies grow, but ex­perts warn of po­ten­tial hic­cups in sup­ply chain; Emer­gent touts grow­ing Covid vac­cine ca­pac­i­ty

5 years ago

Pfiz­er's trou­ble-prone McPher­son plant — now ramp­ing up vac­cine sup­plies — was cit­ed for con­tin­u­ing vi­o­la­tions in ear­ly 2020

5 years ago

Ab­b­Vie of­floads UK site for $119M in sale to Chi­nese cell and gene ther­a­py play­er Phar­maron

5 years ago
Outsourcing
Cell/Gene Tx

No­var­tis pairs up with Cure­Vac to help dri­ve Covid-19 shot pro­duc­tion but may miss the show in the US, EU

5 years ago
Coronavirus

In the lat­est big in­vest­ment in gene ther­a­py man­u­fac­tur­ing, Bio­gen com­mits $200M to a ma­jor new fa­cil­i­ty in NC

5 years ago
Cell/Gene Tx

Swiss CD­MO Celonic finds a home at No­var­tis' Stein hub, plans to add 250 new jobs cen­tered on next-gen drugs

5 years ago
Outsourcing
Cell/Gene Tx

With stars aligned and cash in re­serve, Bob Nelsen's Re­silience plans a makeover at 2 new fa­cil­i­ty ad­di­tions to its drug man­u­fac­tur­ing up­start

5 years ago

Af­ter bail­ing on Covid-19 vac­cines, Mer­ck will team up with J&J to pro­duce its shot as part of un­usu­al Big Phar­ma pact

5 years ago
Coronavirus

A 'love sto­ry': WuXi AppTec wraps UK-based CRO in­to its cell and gene ther­a­py unit

5 years ago
Deals
Outsourcing

Avid Bioser­vices, with re­cent IPO and Covid-19 part­ner­ship in hand, launch­es 2nd phase of fa­cil­i­ty ex­pan­sion

5 years ago
Outsourcing

Biden wants a re­view of the API sup­ply chain. Will that par­lay in­to an ef­fort to 'on­shore' drug man­u­fac­tur­ing?

5 years ago
Outsourcing

CMO Tal Zaks bids Mod­er­na a sur­prise adieu as biotech projects $18.4B in rev­enue, plots post-Covid ex­pan­sion

5 years ago
People

Dutch biotech In­travacc seeks to bol­ster Nether­lands vac­cine man­u­fac­tur­ing abil­i­ties with new plants

5 years ago

With No­vavax vac­cine deal un­der its belt, SK Bio­science plots out March IPO on the Ko­re­an ex­change

5 years ago

Covid-19 man­u­fac­tur­ing roundup: As­traZeneca strug­gling to make planned vac­cine de­liv­er­ies to EU; J&J out­lines plans to pro­vide 100M dos­es of Covid vac­cine in US as Pfiz­er, Mod­er­na promise speed­i­er de­liv­ery

5 years ago

Bris­tol My­ers scales up cell ther­a­py pro­duc­tion with liso-cel nod in hand and an­oth­er ap­proval maybe on the way

5 years ago
Cell/Gene Tx

Catal­ent un­corks play in plas­mid DNA with buy­out of Bel­gian neigh­bor Del­phi, Mary­land ex­pan­sion launch

5 years ago
Outsourcing

Ore­gon's Cas­cade Chem­istry looks to boost its Amer­i­can-made API pro­duc­tion with $14M in­vest­ment

5 years ago

Covid-19 Man­u­fac­tur­ing Roundup: Ther­mo Fish­er plant ramps up As­traZeneca vac­cine pro­duc­tion; No­vavax ex­pands Ko­re­an man­u­fac­tur­ing pact

5 years ago
Coronavirus

End­points Man­u­fac­tur­ing: 5 Ques­tions with Ho­mol­o­gy Med­i­cines

5 years ago
People

Mallinck­rodt be­comes the lat­est vic­tim of the FDA's pan­dem­ic-re­lat­ed de­lays as it push­es off ap­pli­ca­tion for skin graft

5 years ago
Pharma
FDA+

Is­raeli API mak­er Wave­length buys up ma­jor­i­ty stake in In­di­an firm mak­ing drug start­ing ma­te­ri­als and in­ter­me­di­ates

5 years ago
Outsourcing

End­points Man­u­fac­tur­ing: Charles Riv­er makes a splash for cell and gene ther­a­py spe­cial­ist; 5 ques­tions with Ho­mol­o­gy Med­i­cines

5 years ago

Cen­tu­ry Ther­a­peu­tics boosts iP­SC man­u­fac­tur­ing space in New Jer­sey as part of com­pa­ny wide ex­pan­sion

5 years ago
Cell/Gene Tx
First page Previous page 757677787980 Next page Last page
A service from the Financial Times